Posted by Surbhi on July 17 2026 at 03:54 PM
public
The minimal residual disease (MRD) testing market — molecular diagnostic assays that detect trace, sub-clinical cancer cells or circulating tumor DNA remaining after treatment, often months befor...
The global Minimal Residual Disease Market was valued at USD 2.53 billion in 2024 and is expected to reach USD 9.16 billion by 2034, growing at a CAGR of 13.7%. Increasing prevalence of hematolog...
